Non-invasive first-trimester detection of paternal beta-globin gene mutations and polymorphisms as predictors of thalassemia risk at chorionic villous sampling

dc.contributor.authorLazaros, L.en
dc.contributor.authorHatzi, E.en
dc.contributor.authorBouba, I.en
dc.contributor.authorMakrydimas, G.en
dc.contributor.authorDalkalitsis, N.en
dc.contributor.authorStefos, T.en
dc.contributor.authorParaskevaidis, E.en
dc.contributor.authorGeorgiou, I.en
dc.date.accessioned2015-11-24T19:01:49Z
dc.date.available2015-11-24T19:01:49Z
dc.identifier.issn0301-2115-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19728
dc.rightsDefault Licence-
dc.subjectCase-Control Studiesen
dc.subject*Chorionic Villi Samplingen
dc.subjectDNA Mutational Analysisen
dc.subjectFemaleen
dc.subjectGlobins/*geneticsen
dc.subjectHaplotypesen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectPolymorphism, Genetic/*geneticsen
dc.subjectPregnancyen
dc.subjectPregnancy Trimester, First/*geneticsen
dc.subjectSensitivity and Specificityen
dc.subjectbeta-Thalassemia/diagnosis/*geneticsen
dc.titleNon-invasive first-trimester detection of paternal beta-globin gene mutations and polymorphisms as predictors of thalassemia risk at chorionic villous samplingen
heal.abstractOBJECTIVE: The objective was to evaluate the beta-globin gene mutations and polymorphisms in cell-free fetal DNA in the early first trimester (7-9th weeks' gestation) for the prediction of thalassemia risk at chorionic villous sampling (CVS). STUDY DESIGN: Beta-globin gene mutations and polymorphisms were analyzed in 97 carrier families and 100 control couples. Using conventional PCR-DGGE we carried out cell-free fetal DNA analysis in 37 couples in whom only the father was an IVSI-110 carrier. RESULTS: Beta-globin gene mutations have 80% information content in contrast to 39% of polymorphisms. By non-invasive early first-trimester identification of the paternally transmitted IVSI-110 mutation, we reached a sensitivity and specificity of 96 and 100%, respectively. Although the detection rate of the Y chromosome in male fetuses was as high as 100%, beta-thalassemia allele drop-out cannot be excluded. CONCLUSIONS: Even though there is high sensitivity in non-invasive paternally transmitted beta-thalassemia mutation detection, intense effort must be made to avoid misdiagnoses before the clinical application of this approach.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.ejogrb.2007.12.019-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/18353524-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0301211508000523/1-s2.0-S0301211508000523-main.pdf?_tid=8fd86e2a8a85c8aac3fa5627fcc5e9c8&acdnat=1333455547_b9bb822c215eb5d674cb33d8f9ab4aeb-
heal.journalNameEur J Obstet Gynecol Reprod Biolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2008-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: